Correlation Between Day One and Keros Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Keros Therapeutics, you can compare the effects of market volatilities on Day One and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Keros Therapeutics.

Diversification Opportunities for Day One and Keros Therapeutics

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Day and Keros is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Day One i.e., Day One and Keros Therapeutics go up and down completely randomly.

Pair Corralation between Day One and Keros Therapeutics

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.56 times more return on investment than Keros Therapeutics. However, Day One Biopharmaceuticals is 1.78 times less risky than Keros Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Keros Therapeutics is currently generating about -0.22 per unit of risk. If you would invest  1,220  in Day One Biopharmaceuticals on November 9, 2024 and sell it today you would earn a total of  31.00  from holding Day One Biopharmaceuticals or generate 2.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Keros Therapeutics

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Keros Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Keros Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Day One and Keros Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Keros Therapeutics

The main advantage of trading using opposite Day One and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.
The idea behind Day One Biopharmaceuticals and Keros Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios